French study on type 3 Glycogen storage disease
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study tracks the health of people with type 3 Glycogen storage disease. It may help doctors understand the disease better and plan better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of type 3 Glycogen storage disease (GSD3)
- You must agree to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the natural history (how the illness typically progresses) in people with GSD VI or GSD IX. It may help doctors better understand disease patterns, which can support future treatments.
This study follows people with rare types of glycogen storage disease (GSD) over time to learn more about how the disease progresses. It does not test a new treatment but will collect information to help future research.
This study is creating a registry (a database) to better understand glycogen storage diseases in Indian children. If your child has a confirmed genetic diagnosis, joining helps doctors learn more about the condition and improve care.
This study looks at people with Gaucher disease (types I, II, or III) to better “group” patients for understanding and future research. If you (or your child) have confirmed Gaucher disease, you may be asked to share information and follow a study schedule.
This trial tests a medicine called Diazoxide to see if it helps people with type 1 glycogen storage disease (a rare condition that makes it hard for the body to control blood sugar). It is only for patients treated at two specific hospitals in France.
This study looks at liver stiffness (a sign of scarring, called fibrosis) in children and young adults with type III glycogen storage disease. Researchers want to see how common liver fibrosis is in this group and how it changes over time, using a non-invasive ultrasound-like test called elastography.
Hear when a new Glycogen Storage Disease Type III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.